749 related articles for article (PubMed ID: 18840489)
1. Active targeting schemes for nanoparticle systems in cancer therapeutics.
Byrne JD; Betancourt T; Brannon-Peppas L
Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle therapeutics: an emerging treatment modality for cancer.
Davis ME; Chen ZG; Shin DM
Nat Rev Drug Discov; 2008 Sep; 7(9):771-82. PubMed ID: 18758474
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
5. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
Abu Lila AS; Ishida T; Kiwada H
Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
Gindy ME; Prud'homme RK
Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
9. Towards the use of nanoparticles in cancer therapy and imaging.
Pauwels EK; Erba P
Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
Bouzin C; Feron O
Drug Resist Updat; 2007 Jun; 10(3):109-20. PubMed ID: 17452119
[TBL] [Abstract][Full Text] [Related]
11. Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer.
Molema G
Acta Biochim Pol; 2005; 52(2):301-10. PubMed ID: 15990916
[TBL] [Abstract][Full Text] [Related]
12. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells.
Schiffelers RM; Storm G
Int J Pharm; 2008 Dec; 364(2):258-64. PubMed ID: 18773947
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive nanoparticles for cancer drug delivery.
Shen Y; Tang H; Radosz M; Van Kirk E; Murdoch WJ
Methods Mol Biol; 2008; 437():183-216. PubMed ID: 18369970
[TBL] [Abstract][Full Text] [Related]
14. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
15. [Targeted anticancer drugs and their development].
Kervinen J; Gahmberg CG
Duodecim; 2004; 120(19):2323-30. PubMed ID: 15565985
[No Abstract] [Full Text] [Related]
16. Optimizing the delivery of cancer drugs that block angiogenesis.
Cao Y; Langer R
Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
[TBL] [Abstract][Full Text] [Related]
17. Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
Chaplin DJ; Hill SA
Curr Opin Investig Drugs; 2002 Sep; 3(9):1381-4. PubMed ID: 12498016
[No Abstract] [Full Text] [Related]
18. Nanoparticles for drug delivery in cancer treatment.
Haley B; Frenkel E
Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
[TBL] [Abstract][Full Text] [Related]
19. Role of tumor vascular architecture in drug delivery.
Narang AS; Varia S
Adv Drug Deliv Rev; 2011 Jul; 63(8):640-58. PubMed ID: 21514334
[TBL] [Abstract][Full Text] [Related]
20. Composite nanoparticles take aim at cancer.
Gil PR; Parak WJ
ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
